Navigation Links
Anthony A. Charity Joins Tunnell Consulting
Date:12/10/2013

King of Prussia, PA (PRWEB) December 10, 2013

Tunnell Consulting, Inc. today announced that Anthony A. Charity, who served in the U.S. Food and Drug Administration (FDA) for more than twenty years, has joined the firm as a Managing Consultant, Quality and Compliance.

“Anthony Charity’s experience at the FDA enables him to provide our life sciences clients with invaluable help in understanding good manufacturing practices, preparing for inspections, and mitigating compliance risks,” said Philippe Cini, Ph.D., Group Vice President. “His expertise complements Tunnell’s longstanding strengths in quality and compliance, areas in which excellence is absolutely critical for pharmaceutical companies.”

Prior to joining Tunnell, Mr. Charity served as FDA Branch Chief for the Dedicated Drug Cadre Division of Medical Products and Tobacco Inspection, Rockville, MD, where he supervised drug investigators who inspected the foreign manufacturing operations of firms who market pharmaceutical products in the U.S.

“I am delighted to join Tunnell’s Quality and Compliance practice, with its long track record of success, its exclusive focus on the pharmaceutical industry, and its proven methodologies for addressing quality and compliance,” said Mr. Charity. “In a regulatory environment that is becoming increasingly science-driven, the firm offers to clients a breadth and depth of resources that is hard to match.”

Prior to his role as a Branch Chief, Mr. Charity served as a Compliance Officer for the FDA’s Center for Drug Evaluation and Research (CDER), Division of Manufacturing and Product Quality. At CDER, he reviewed proposed regulatory actions for conclusiveness and acceptability of evidence; nature and extent of deviations from current good manufacturing practices (cGMPs), and appropriate regulatory action strategy. He is expert at identifying and evaluating cGMP problems in the manufacture and control of active pharmaceutical ingredients (APIs) and intermediates and their impact on the quality of finished pharmaceuticals.

He also authored the “Active Pharmaceutical Ingredient Process Inspection Compliance Program Guidance Manual 7356.002F,” a comprehensive cGMP inspection guide for determining whether a manufacturer of APIs is operating in a state of control.

He began his career with the FDA as the Consumer Safety Officer, U.S. Custom House, Philadelphia, PA, where he conducted inspections in industries that were regulated by the FDA, primarily in the pharmaceutical, bioresearch monitoring and good laboratory practices areas.

Mr. Charity received his B.A. in Chemistry from Cheyney State University, Cheyney, PA.

About Tunnell Consulting
Founded in 1962 and serving many of the world’s leading life sciences firms and government agencies, Tunnell Consulting, Inc. integrates strategic, technical, process, and organizational skills to design and implement sustainable solutions that exactly meet client needs. With deep industry knowledge, extensive scientific credentials, and superior measurable results, we consistently boost the operating performance of each unique client we serve.

Read the full story at http://www.prweb.com/releases/2013/12/prweb11401819.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Dwaine Rieves, MD, Anthony Di Santo, PhD and Joachim Vollmar, MSc Join NDA Partners as Premier Expert Consultants
2. Aviir Diagnostics Laboratory in Collaboration with Cause;ology Sponsors "Storyland," a Red Carpet Charity Extravaganza in Hollywood
3. ALS TDI Tri-State Trek Charity Bike Ride to Take Place July 19-21
4. Vet-Stem, Inc. Founder, Robert Harman, DVM, Invited as Inspirational Speaker for the 6th Annual After the Finish Line Charity Dinner
5. Michael Cusumano, MITs Sloan Distinguished Professor of Management, Joins Quantum Leap Innovations Board of Directors
6. Robert Farrell Joins Bionovos Board of Directors
7. Former Sanofi-aventis and US Oncology Executive Joins New Century Health as Chief Executive Officer
8. Scott Brooks Joins Regenesis Biomedical as Chief Operating Officer
9. First Choice Rehabilitation Specialists Joins Select Medical
10. Excel Life Sciences Joins DATATRAKs Connect Partner Program
11. Marina Biotech, Inc. Joins OTCQX
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2017)... San Diego, CA (PRWEB) , ... May 20, ... ... decision support tool that helps avoid the lengthy trial and error process by ... for patients. It can also strengthen the doctor-patient relationship through a personalized ...
(Date:5/18/2017)... ... May 18, 2017 , ... Dr. Ralph Mobbs ... the Prince Of Wales Private Hospital. The procedure was performed on a 46-year-old ... failed conservative treatments prior to undergoing surgery. , The AxioMed viscoelastic disc is ...
(Date:5/18/2017)... ... May 17, 2017 , ... NDA Partners Chairman Carl ... CEO of Eurofins Advantar Laboratories and President of Pharmaceutical Development Business Unit of Cardinal ... at Eurofins and Cardinal Health, he was former Chief Operating Officer at Anaborex, Senior ...
(Date:5/18/2017)... SANTA BARBARA, CALIFORNIA (PRWEB) , ... May 17, ... ... risk management, technological innovation and business process optimization firm for the life sciences ... the Chairman of the UDIs and Traceability for Medical Devices conference in Brussels, ...
Breaking Biology Technology:
(Date:4/3/2017)... , April 3, 2017  Data ... precision engineering platform, detected a statistically significant ... product prior to treatment and objective response ... the potential to predict whether cancer patients ... to treatment, as well as to improve ...
(Date:3/29/2017)... CHICAGO , March 29, 2017  higi, the ... ecosystem in North America , today ... Partners and the acquisition of EveryMove. The new investment ... extensive set of tools to transform population health activities ... and lifestyle data. higi collects and secures ...
(Date:3/24/2017)... 2017 Research and Markets has announced the ... & Trends - Industry Forecast to 2025" report to their ... The Global ... CAGR of around 15.1% over the next decade to reach approximately ... the market estimates and forecasts for all the given segments on ...
Breaking Biology News(10 mins):